Ginkgo Biosecurity and Illumina collaborate to deploy biosurveillance technologies around the world

January 19 2024

We’re thrilled to announce that Ginkgo Biosecurity has entered into a Co-Marketing Agreement with Illumina, Inc., a global leader in DNA sequencing and array-based technologies, to partner on expanding biosecurity capabilities globally.

With over a dozen countries actively scoping and hosting biosecurity programs with Ginkgo’s platform of integrated biosecurity services, our bioradar network can serve to bolster national security and early warning capabilities. Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Illumina offers a range of leading next-generation sequencing instruments, consumables, and software to understand pathogens in ways not previously possible. These solutions can be leveraged to interrogate many different types of specimens, to enable stakeholders with a full understanding of circulating threats.

Together we will aim to demonstrate the use of Illumina products with Ginkgo’s bioradar, to accelerate the expansion of the pathogen monitoring network in a way that empowers countries, as well as increase the scale and scope of pathogen genomic surveillance globally. Ginkgo Biosecurity and Illumina will work together to market our solutions, with the aim to enhance early warning of emerging and novel pathogens and fill gaps in global biosurveillance infrastructure.

“Without sustained investments in global early detection, we remain deeply vulnerable to the next novel pathogen threat. Through this relationship with Illumina, Ginkgo aims to accelerate deployment of our early warning and bioradar programs for governments worldwide as they seek to modernize defenses against biological threats,” said Matt McKnight, General Manager for Biosecurity at Ginkgo Bioworks. “Sustained genomic monitoring capacity is urgently needed to drive risk identification and collective response ahead of potential pandemics and emerging biothreats.”

Read more.

Read Next
Previous Article
December 18, 2023
A New Paradigm in Biosecurity: The Vision of BIOINT
Next Article
January 24, 2024
Rwanda is building a disease intelligence system